Financial Overview

(Unless otherwise stated, the number is in million RMB)

2021 2020 2019 2018 2017
Turnover 8,337.2 6,946.0 6,073.6 5,433.4 5,348.8
Turnover (In the case that all medicines were directly sold by the Group) 9,230.2 7,395.2 6,416.3 5,799.6 5,332.0
Profit for the Year 3,025.3 2,555.7 1,955.7 1,844.6 1,669.9
Basic EPS (RMB Yuan) 1.2228 1.0237 0.7905 0.7441 0.6734
Total Dividend Per Share for the Year (RMB Yuan) 0.4910 0.4138 0.3154 0.2970 0.2686
Gearing Ratio 10.6% 4.6% 6.2% 13.9% 20.7%
Return on Equity 25.3% 24.8% 21.8% 23.4% 24.6%

*For the year ended 31 December

Financial Highlights For the Latest Ten Years

Turnover

营业额

*In the case that all medicines were directly sold by the Group

Profit for the Year

年度溢利

Dividend Payout Ratio

派息比率与股息率

ROE

ROE